Affinity DataIC50: 58nMAssay Description:Displacement of 0.5 nM [3H](R)-(+)-WIN-55212-2 from Cannabinoid receptor of rat cerebellar membranesMore data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair